| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $477K | — | -91.2% |
| R&D Expense | $2.8M | — | -16.4% |
| SG&A Expense | $12.7M | — | +25.7% |
| Operating Income | -$16.5M | — | +49.4% |
| Pre-tax Income | -$17.6M | — | +33.1% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$17.6M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.2M | -41.7% | -56.2% |
| Accounts Receivable | $5.4M | -58.9% | -72.0% |
| Inventory | $682K | -0.3% | -21.2% |
| Current Assets | $50.5M | -37.5% | -57.7% |
| Total Assets | $135.1M | -14.3% | -61.3% |
| Current Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.9M | — | +42.3% |
| Capital Expenditures | $7.0M | — | -0.4% |
| Investing Cash Flow | $244K | — | -54.8% |
| Financing Cash Flow | -$8.6M | — | -90.2% |
| Free Cash Flow | -$11.8M | — | +23.3% |
| +33.2% |
| EPS (Basic) | -$3.28 | — | -1722.2% |
| EPS (Diluted) | -$3.28 | — | -1722.2% |
| $19.0M |
| -33.3% |
| +51.3% |
| Total Liabilities | $46.8M | -12.5% | +36.0% |
| Stockholders' Equity | $88.3M | -15.2% | -71.9% |